Selection and education of patients for inhaled insulin

Srikanth Bellary, Anthony H. Barnett

Research output: Contribution to journalArticle

Abstract

Inhaled insulin is a recent advance in insulin delivery that promises to be an effective alternative to subcutaneous insulin. Several insulin delivery systems are currently in development and the first of these has been approved for clinical use. Inhaled insulin offers greater flexibility and convenience for patients with diabetes and may be particularly useful in those who are reluctant to initiate or intensify insulin treatment. Although promising, potential concerns remain regarding its long-term effects on lungs. Also, excluding certain groups of patients such as smokers and those with respiratory illnesses will restrict its use at present. Lack of familiarity with the technology, especially relating to dose adjustments and inhaler device, is also likely to present fresh challenges. But, careful selection of patients, education, and continued support from health professionals is vital to ensure success with this new technology.
Original languageEnglish
Pages (from-to)363-368
Number of pages6
JournalCurrent Diabetes Reports
Volume7
Issue number5
DOIs
Publication statusPublished - 1 Oct 2007

Fingerprint

Patient Education
Insulin
Technology
Social Adjustment
Nebulizers and Vaporizers
Equipment and Supplies
Lung
Health

Keywords

  • inhalation administration
  • oral administration
  • type 1 diabetes mellitus
  • type 2 diabetes mellitus
  • smoking
  • hypoglycemic agents
  • insulin
  • respiratory function tests
  • patient selection

Cite this

Bellary, Srikanth ; Barnett, Anthony H. / Selection and education of patients for inhaled insulin. In: Current Diabetes Reports. 2007 ; Vol. 7, No. 5. pp. 363-368.
@article{21893d53303f476686a894be7677209e,
title = "Selection and education of patients for inhaled insulin",
abstract = "Inhaled insulin is a recent advance in insulin delivery that promises to be an effective alternative to subcutaneous insulin. Several insulin delivery systems are currently in development and the first of these has been approved for clinical use. Inhaled insulin offers greater flexibility and convenience for patients with diabetes and may be particularly useful in those who are reluctant to initiate or intensify insulin treatment. Although promising, potential concerns remain regarding its long-term effects on lungs. Also, excluding certain groups of patients such as smokers and those with respiratory illnesses will restrict its use at present. Lack of familiarity with the technology, especially relating to dose adjustments and inhaler device, is also likely to present fresh challenges. But, careful selection of patients, education, and continued support from health professionals is vital to ensure success with this new technology.",
keywords = "inhalation administration, oral administration, type 1 diabetes mellitus, type 2 diabetes mellitus, smoking, hypoglycemic agents, insulin, respiratory function tests, patient selection",
author = "Srikanth Bellary and Barnett, {Anthony H.}",
year = "2007",
month = "10",
day = "1",
doi = "10.1007/s11892-007-0059-6",
language = "English",
volume = "7",
pages = "363--368",
journal = "Current Diabetes Reports",
issn = "1534-4827",
publisher = "Current Medicine Group",
number = "5",

}

Selection and education of patients for inhaled insulin. / Bellary, Srikanth; Barnett, Anthony H.

In: Current Diabetes Reports, Vol. 7, No. 5, 01.10.2007, p. 363-368.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Selection and education of patients for inhaled insulin

AU - Bellary, Srikanth

AU - Barnett, Anthony H.

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Inhaled insulin is a recent advance in insulin delivery that promises to be an effective alternative to subcutaneous insulin. Several insulin delivery systems are currently in development and the first of these has been approved for clinical use. Inhaled insulin offers greater flexibility and convenience for patients with diabetes and may be particularly useful in those who are reluctant to initiate or intensify insulin treatment. Although promising, potential concerns remain regarding its long-term effects on lungs. Also, excluding certain groups of patients such as smokers and those with respiratory illnesses will restrict its use at present. Lack of familiarity with the technology, especially relating to dose adjustments and inhaler device, is also likely to present fresh challenges. But, careful selection of patients, education, and continued support from health professionals is vital to ensure success with this new technology.

AB - Inhaled insulin is a recent advance in insulin delivery that promises to be an effective alternative to subcutaneous insulin. Several insulin delivery systems are currently in development and the first of these has been approved for clinical use. Inhaled insulin offers greater flexibility and convenience for patients with diabetes and may be particularly useful in those who are reluctant to initiate or intensify insulin treatment. Although promising, potential concerns remain regarding its long-term effects on lungs. Also, excluding certain groups of patients such as smokers and those with respiratory illnesses will restrict its use at present. Lack of familiarity with the technology, especially relating to dose adjustments and inhaler device, is also likely to present fresh challenges. But, careful selection of patients, education, and continued support from health professionals is vital to ensure success with this new technology.

KW - inhalation administration

KW - oral administration

KW - type 1 diabetes mellitus

KW - type 2 diabetes mellitus

KW - smoking

KW - hypoglycemic agents

KW - insulin

KW - respiratory function tests

KW - patient selection

UR - http://link.springer.com/article/10.1007/s11892-007-0059-6

U2 - 10.1007/s11892-007-0059-6

DO - 10.1007/s11892-007-0059-6

M3 - Article

VL - 7

SP - 363

EP - 368

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 5

ER -